# Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

> **NCT02165033** · PHASE1 · COMPLETED · sponsor: **Intech Biopharm Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/Procaterol 180/10 X 4 puffs

## Key facts

- **NCT ID:** NCT02165033
- **Lead sponsor:** Intech Biopharm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02165033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02165033, "Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02165033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*